PA
VH

VML Health | Market Access

Enterprise platforms and creative strategies accelerating pharma HCP engagement and market access.

Visit Website

Known For

AI-powered, pharma-specific SaaS platforms with superior UX

Key Differentiators

  • AI-powered, pharma-specific SaaS platforms with superior UX
  • backed by 30k-employee creative-tech network
  • full-spectrum HCP lifecycle support unmatched elsewhere.

Overview

VML Health, the health division of VML (WPP), specializes in creative communications, digital transformation, and SaaS platforms for pharma HCP/KOL engagement, medical affairs, and payer/market access strategies. No standalone “Market Access” unit; integrated into health services with tools like Superfly for enterprise ops.

Services & Capabilities

  • KOL/HCP platforms (mapping, engagement, insights, contracts via Superfly, X-fly, SkyBoard)
  • payer marketing & access comms
  • medical education
  • AI MedInfo
  • advisory boards
  • field medical excellence programs
  • creative brand strategy.

Competitive Position

  • AI-powered, pharma-specific SaaS platforms with superior UX
  • backed by 30k-employee creative-tech network
  • full-spectrum HCP lifecycle support unmatched elsewhere.

Recent Developments

2024: Record $504.6M revenue (+3%); new wins incl. J&J, AstraZeneca, Sanofi; launched Enterprise Solutions (tech partnerships Adobe/Google/Microsoft); KOL platform partnership w/Definitive Healthcare (Superfly); leadership adds (Jason Reese global chief transformation officer); awards (Cannes Lions Grand Prix, ADC); campaigns (Abbott diabetes s…

Client & Partner Ecosystem

AstraZeneca, Genentech, J&J Innovative Medicine, Gilead, Boehringer Ingelheim, Sanofi, Perrigo; partners: Definitive Healthcare, Kyndryl; AstraZeneca, Johnson & Johnson, Sanofi (new 2024 wins); Abbott; Perrigo (women’s health/OTC); Ford (health campaigns)

Technology Platform

Superfly (KOL CRM/engagement); X-fly; SkyBoard; Enterprise platforms MAP, Diff, Satalia

Therapeutic Focus

broad/all

Target Customers

Pharmaceutical brand teams, medical affairs; biotech, HealthTech

Sources